The global Virus Filtration Market is expected to reach US$ 5,555.4 Mn in 2025 from US$ 2,139.4 Mn in 2017. The market is estimated to grow with a CAGR of 13.0% from 2018-2025. The report highlights the trends prevalent in the global virus filtration market and the factors driving the market along with those that act as restraints to its growth. The global virus filtration market is witnessing a sheer rise in the current scenario and is expected to expand in the coming years. Increasing investments in R&D and outsourcing activities among pharmaceutical and medical devices manufacturers is one of the major factor to propel the demand of virus filtration market. However, consolidation prevalent in the market is expected to hinder the market growth.
Regulatory authorities such as Food & Drug Administration, European Medicine Agency (EMA) and others has consistently shown a tough stance towards pharmaceutical can biotechnology manufacturers. The industry players are compiled to maintain their awareness and abide by the updated regulations pertaining to current good manufacturing practices (cGMP) as well as good laboratory practices (GLP) to assure proper design, monitoring, and control of manufacturing processes and facilities.
The US Food and Drug Administration released a document of guidelines and requirements for biotechnology and pharmaceutical manufacturers in 1998 that intends on virus safety evaluation of biotechnology and pharmaceutical products that are derived from cell lines of human or animal origin. The stringent regulations enforced by healthcare governing bodies to perform virus clearance tests during the drug development procedures is expected to increase the demand of virus filtration market not only in the pharmaceutical sectors but also in the medical device manufacturing capabilities that uses mammalian derived cell lines. Moreover, the streamlining regulatory framework in the emerging markets such as India to realign the quality of the manufacturing process is further expected to propel the market growth.
Get PDF Sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001427/
Global virus filtration market, based on the application was segmented into biologics, medical devices water purification and air purification. In 2017, biologics segment held the largest share of the market, by application. Moreover, the biologics segment is expected to grow at the fastest rate during the coming years owing to owing to the rise in the production of biologics and increasing government funding as well as promotional initiatives undertaken for usage of biologics to treat various medical conditions. Increasing R&D innovation in various other applications such as gene therapy and stem cell biology has also been contributing significantly to the growth of this market.
The market players are adopting inorganic strategies to mark their growth in the highly competitive virus filtration market. The companies are undergoing collaborations, mergers, acquisitions, and partnership ventures to expand the products as well as service portfolio by leveraging the expertise of the other companies and using it in the advantage to attain market growth. For instance, in April 2016, Charles River, Inc.
The major players operating in the virus filtration market include Merck KGaA, Danaher (Pall Corporation) and Sartorius AG, Thermo Fisher Scientific Inc., General Electric, Lonza, Charles River, WuXi AppTec, Asahi Kasei Medical Co., Ltd. and Clean Cells among others.
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
